Royalty Pharma plcRPRX
那斯達克 · USD
53.55
+0.49
(+0.92%)
收盤 05/22 03:59 (UTC+8)
05/22 03:59 (UTC+8)
Royalty Pharma plcRPRX
53.55
+0.49
(+0.92%)
財務數據
損益表
- 5.96
- 5.68
- 5.37
- 5.65
- 5.94
- 5.68
- 5.79
- 6.09
- 6.22
- 6.31
- 11.14
- -4.71
- -5.41
- 5.10
- 5.13
- -4.28
- 1.83
- 5.29
- 2.08
- 1.38
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 630,576 | 621,990 | 609,291 | 578,665 | 568,247 | 593,641 | 564,690 | 537,267 | 567,978 | 596,068 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 630,576 | 621,990 | 609,291 | 578,665 | 568,247 | 593,641 | 564,690 | - | 567,978 | 596,068 |
營業費用 | 67,538 | 233,608 | 182,135 | 368,867 | 34,065 | - | -170,384 | - | 641,752 | -16,828 |
研發費用 | 39,790 | 50,500 | 50,500 | 300,500 | 50,500 | 500 | 500 | 500 | 500 | 500 |
推銷及管理費用 | -41,695 | 183,108 | 131,635 | 68,367 | -16,435 | 231,627 | -170,884 | 267,137 | 641,252 | -17,328 |
非經常性項目費用 | 69,443 | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 563,038 | 388,382 | 427,156 | 209,798 | 534,182 | 361,514 | 735,074 | 269,630 | -73,774 | 612,896 |
其他收入及費用 | -2,652 | 21,981 | 61,808 | -23,635 | 3,947 | 48,854 | 76,534 | 19,181 | 50,152 | 96,532 |
利息費用 | 93,722 | 94,171 | 79,564 | 68,668 | 65,261 | 65,761 | 66,506 | 49,013 | 44,232 | 47,255 |
稅前純益 | 468,256 | 355,913 | 444,211 | 89,635 | 434,433 | 334,351 | 806,358 | 194,377 | -4,273 | 717,586 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | 294,690 | 214,205 | 288,217 | 29,176 | 239,349 | 208,214 | 543,987 | 102,004 | 4,778 | 494,340 |
基本每股稅後盈餘(元) | 0.67 | 0.50 | 0.67 | 0.07 | 0.55 | 0.47 | 1.22 | 0.23 | 0.01 | - |
稀釋每股稅後盈餘(元) | 0.67 | 0.50 | 0.66 | 0.07 | 0.55 | 0.47 | 1.20 | 0.23 | 0.01 | 1.10 |
基本平均股數(千股) | 443628.00 | 428669.00 | 431887.00 | 423514.00 | 435480.00 | 445985.00 | 446038.00 | 451020.00 | 448623.00 | - |
稀釋平均股數(千股) | 557000.00 | 556000.00 | 559611.00 | 562298.00 | 578102.00 | 589000.00 | 593000.00 | 596912.00 | 597479.00 | - |
還原基本每股稅後盈餘(元) | 0.67 | 0.50 | 0.67 | 0.07 | 0.55 | 0.47 | 1.22 | 0.23 | 0.01 | - |
還原稀釋每股稅後盈餘(元) | 0.67 | 0.50 | 0.66 | 0.07 | 0.55 | 0.47 | 1.20 | 0.23 | 0.01 | 1.10 |
還原基本平均股數(千股) | 443,628 | 428,669 | 431,887 | 423,514 | 435,480 | 445,985 | 446,038 | 451,020 | 448,623 | - |
還原稀釋平均股數(千股) | 557,000 | 556,000 | 559,611 | 562,298 | 578,102 | 589,000 | 593,000 | 596,912 | 597,479 | - |
EBITDA(千元) | 388,412 | 308,376 | 367,781 | 97,844 | 304,610 | 273,975 | 610,493 | 151,017 | 49,010 | 541,595 |